Nigeria is set to receive its first consignments of the landmark Lenacapavir, a new HIV prevention medicine, in March 2026, the federal government has disclosed.
In a statement on Monday, the National Agency for the Control of AIDS said work is already under way to introduce the injectable drug as part of the country’s pre-exposure prophylaxis programme.
The agency described the move as a critical step in strengthening HIV prevention efforts and hastening progress towards ending the epidemic.
